Vascular endothelial growth factor-targeted therapy in patients with renal cell carcinoma pretreated with immune checkpoint inhibitors: A systematic literature review
Cancer Treatment Reviews · 2024
DOI: 10.1016/j.ctrv.2023.102652 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Cancer Treatment Reviews, 2024. Verfasst von Laurence Albiges und 8 weiteren Autor:innen. Beteiligte Einrichtung: Medical Oncology, Gustave Roussy, Université Paris-Saclay, Villejuif, France. Electronic address: laurence.albiges@gustaveroussy.fr. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms, Vascular Endothelial Growth Factor A. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ipsen, Ipsen Ltd UK.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medical Oncology, Gustave Roussy, Université Paris-Saclay, Villejuif, France. Electronic address: laurence.albiges@gustaveroussy.fr.
- Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
- Division of Medical Oncology, Tom Baker Cancer Centre, University of Calgary, Calgary, AB, Canada.
- Genitourinary Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
- University Hospital 12 de Octubre, Department of Medical Oncology, Madrid, Spain.
- Ipsen, Boulogne-Billancourt, France.
Förderung
- Ipsen
- Ipsen Ltd UK
Zitieren
APA
Albiges, L., McGregor, B. A., Heng, D. Y. C., Procopio, G., de Velasco, G., Taguieva-Pioger, N., Martín-Couce, L., Tannir, N. M., & Powles, T. (2024). Vascular endothelial growth factor-targeted therapy in patients with renal cell carcinoma pretreated with immune checkpoint inhibitors: A systematic literature review. Cancer Treatment Reviews. https://doi.org/10.1016/j.ctrv.2023.102652
Vancouver
Albiges L, McGregor BA, Heng DYC, Procopio G, de Velasco G, Taguieva-Pioger N, et al. Vascular endothelial growth factor-targeted therapy in patients with renal cell carcinoma pretreated with immune checkpoint inhibitors: A systematic literature review. Cancer Treatment Reviews. 2024. doi:10.1016/j.ctrv.2023.102652
BibTeX
@article{Albiges2024,
author = {Albiges, Laurence and McGregor, Bradley A and Heng, Daniel Y C and Procopio, Giuseppe and de Velasco, Guillermo and Taguieva-Pioger, Naila and Martín-Couce, Lidia and Tannir, Nizar M and Powles, Thomas},
title = {Vascular endothelial growth factor-targeted therapy in patients with renal cell carcinoma pretreated with immune checkpoint inhibitors: A systematic literature review},
journal = {Cancer Treatment Reviews},
year = {2024},
doi = {10.1016/j.ctrv.2023.102652}
}
EUVIMED